Gastrointestinal and Pancreatic Cancer Program

Medical Director: J. Marc Pipas, MD
Scientific Director, Pancreas Program: Murray Korc, MD

The Gastrointestinal Cancer Program provides multidisciplinary review of all gastrointestinal cancer cases arising from the following sites: esophagus, stomach, small intestine, colon, rectum, anus, liver, and pancreas, as well as truncal and extremity sarcomas. The program integrates research protocol opportunities with established treatment algorithms, and evaluates new research ideas and clinical therapies for the treatment of patients with gastrointestinal cancers.

Listen to the Cancer Center Grand Rounds in which Dr. Pipas explains his team's breakthrough pancreatic cancer treatment.

• Intraoperative radiation therapy
• Endoscopic ultrasound and biopsy techniques for staging of gastrointestinal cancers
• Chemo-embolization of unresectable hepatic malignancies
• Radiofrequency ablation of hepatic malignancies
• Hepatic, pancreatic, sarcoma, and esophageal surgery

• Neoadjuvant chemotherapy and radiation therapy for pancreatic and esophageal cancers
• Dendritic cell vaccine therapy for metastatic colorectal cancer
• Chemoprevention of colon cancer
• Adjuvant chemoradiation after gastric cancer resection
• Neoadjuvant chemotherapy and radiation therapy for sarcomas
• Phase I agents for multiple histologic tumor types